38 in Phase 3, 295 total. unsure how many were added i should have jotted that down. 1 BLA by end of Yr and 6 next yr.
the stork insurance is a crock IMO. glad to hear they are not going to pursue any other products of that nature.
they expect 2mm to 20mm per commercialized product so we should be seeing a ramp up on our current 2 to add 3.5mm over the next 12 months on the low end. where did they get the 20mm top end figure from. Do we have a blockbuster in clinical trials that leads us to believe we can have explosive revenue from 1 specific indication.
here is to hoping we can get close to profitability in 2019 though not holding my breath
News 
Market Data 
Discover 
